• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于脑内受体介导药物递送的 basigin 单克隆抗体的特性。

Characterization of basigin monoclonal antibodies for receptor-mediated drug delivery to the brain.

机构信息

Department of Biomedicine, Aarhus University, Høegh-Guldbergsgade 10, Building 1116, 8000, Aarhus C, Denmark.

Department of Biotherapeutic Discovery, H. Lundbeck A/S, Copenhagen, Denmark.

出版信息

Sci Rep. 2020 Sep 3;10(1):14582. doi: 10.1038/s41598-020-71286-2.

DOI:10.1038/s41598-020-71286-2
PMID:32884039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7471916/
Abstract

The brain uptake of biotherapeutics for brain diseases is hindered by the blood-brain barrier (BBB). The BBB selectively regulates the transport of large molecules into the brain and thereby maintains brain homeostasis. Receptor-mediated transcytosis (RMT) is one mechanism to deliver essential proteins into the brain parenchyma. Receptors expressed in the brain endothelial cells have been explored to ferry therapeutic antibodies across the BBB in bifunctional antibody formats. In this study, we generated and characterized monoclonal antibodies (mAbs) binding to the basigin receptor, which recently has been proposed as a target for RMT across the BBB. Antibody binding properties such as affinity have been demonstrated to be important factors for transcytosis capability and efficiency. Nevertheless, studies of basigin mAb properties' effect on RMT are limited. Here we characterize different basigin mAbs for their ability to associate with and subsequently internalize human brain endothelial cells. The mAbs were profiled to determine whether receptor binding epitope and affinity affected receptor-mediated uptake efficiency. By competitive epitope binning studies, basigin mAbs were categorized into five epitope bins. mAbs from three of the epitope bins demonstrated properties required for RMT candidates judged by binding characteristics and their superior level of internalization in human brain endothelial cells.

摘要

治疗脑部疾病的生物疗法的脑部摄取受到血脑屏障 (BBB) 的阻碍。BBB 选择性地调节大分子进入大脑的运输,从而维持大脑内环境的稳定。受体介导的转胞吞作用 (RMT) 是将必需蛋白质递送到脑实质中的一种机制。已经探索了在双功能抗体形式中穿过 BBB 输送治疗性抗体的脑内皮细胞表达的受体。在这项研究中,我们生成并鉴定了与 basigin 受体结合的单克隆抗体 (mAb),该受体最近被提议作为 RMT 穿过 BBB 的靶点。抗体结合特性,如亲和力,已被证明是转胞吞作用能力和效率的重要因素。然而,关于 basigin mAb 特性对 RMT 的影响的研究有限。在这里,我们研究了不同的 basigin mAb 与人类脑内皮细胞结合和随后内化的能力。对 mAb 进行了分析,以确定受体结合表位和亲和力是否影响受体介导的摄取效率。通过竞争性表位 binning 研究,basigin mAb 被分为五个表位 bin。通过结合特性和在人脑内皮细胞中的内化水平判断,来自三个表位 bin 的 mAb 具有 RMT 候选物所需的特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/151e070734c7/41598_2020_71286_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/a5e737ef5abd/41598_2020_71286_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/729c037983c5/41598_2020_71286_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/dcddbcd32375/41598_2020_71286_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/a6ee45aca44f/41598_2020_71286_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/6bcf4b1ae105/41598_2020_71286_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/151e070734c7/41598_2020_71286_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/a5e737ef5abd/41598_2020_71286_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/729c037983c5/41598_2020_71286_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/dcddbcd32375/41598_2020_71286_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/a6ee45aca44f/41598_2020_71286_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/6bcf4b1ae105/41598_2020_71286_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b5a/7471916/151e070734c7/41598_2020_71286_Fig6_HTML.jpg

相似文献

1
Characterization of basigin monoclonal antibodies for receptor-mediated drug delivery to the brain.用于脑内受体介导药物递送的 basigin 单克隆抗体的特性。
Sci Rep. 2020 Sep 3;10(1):14582. doi: 10.1038/s41598-020-71286-2.
2
Basigin Antibodies with Capacity for Drug Delivery Across Brain Endothelial Cells.具有跨脑内皮细胞进行药物递送能力的基底膜聚糖抗体。
Mol Neurobiol. 2021 Sep;58(9):4392-4403. doi: 10.1007/s12035-021-02421-x. Epub 2021 May 20.
3
Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration.系统给药后多价和多特异性 DVD-Ig 蛋白的脑摄取。
MAbs. 2018 Jul;10(5):765-777. doi: 10.1080/19420862.2018.1465159. Epub 2018 Jun 5.
4
Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis.使用微透析法测定大鼠体内抗转铁蛋白受体抗体亲和变体的脑药代动力学。
MAbs. 2021 Jan-Dec;13(1):1874121. doi: 10.1080/19420862.2021.1874121.
5
Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.大鼠转铁蛋白受体抗体 OX26 在体外通过血脑屏障的细胞内分拣和胞吞作用依赖于其结合亲和力。
J Neurochem. 2018 Sep;146(6):735-752. doi: 10.1111/jnc.14482. Epub 2018 Aug 16.
6
Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human.介导受体介导胞吞作用(RMT)的受体在小鼠和人类脑微血管、脑实质和外周组织中的差异表达。
Fluids Barriers CNS. 2020 Jul 22;17(1):47. doi: 10.1186/s12987-020-00209-0.
7
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies.发现新型血脑屏障靶点以增强治疗性抗体向脑内的传递。
Neuron. 2016 Jan 6;89(1):70-82. doi: 10.1016/j.neuron.2015.11.024. Epub 2015 Dec 10.
8
Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS.使用基于人诱导多能干细胞的血脑屏障模型进行抗体筛选,可识别出在中枢神经系统中蓄积的抗体。
FASEB J. 2020 Sep;34(9):12549-12564. doi: 10.1096/fj.202000851R. Epub 2020 Jul 30.
9
Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.利用受体介导的转胞吞作用将治疗剂通过血脑屏障递送至大脑的智能策略。
Chem Pharm Bull (Tokyo). 2020;68(4):316-325. doi: 10.1248/cpb.c19-00854.
10
Human Immortalized Cell-Based Blood-Brain Barrier Spheroid Models Offer an Evaluation Tool for the Brain Penetration Properties of Macromolecules.基于人永生化细胞的血脑屏障球体模型为大分子的脑穿透性质提供了一种评估工具。
Mol Pharm. 2022 Aug 1;19(8):2754-2764. doi: 10.1021/acs.molpharmaceut.2c00120. Epub 2022 Jun 29.

引用本文的文献

1
High-Throughput Epitope Binning Analysis of Human Monoclonal Antibodies to Assess Epitope Diversity Using the Octet Bio-Layer Interferometry Platform.使用Octet生物层干涉平台对人单克隆抗体进行高通量表位分组分析以评估表位多样性
Methods Mol Biol. 2025;2937:297-323. doi: 10.1007/978-1-0716-4591-8_18.
2
Ex vivo nanoscale abluminal mapping of putative cargo receptors at the blood-brain barrier of expanded brain capillaries.体外扩张脑毛细血管血脑屏障中潜在货物受体的纳米级向腔侧绘图。
Fluids Barriers CNS. 2024 Oct 14;21(1):80. doi: 10.1186/s12987-024-00585-x.
3
The proteome of the blood-brain barrier in rat and mouse: highly specific identification of proteins on the luminal surface of brain microvessels by in vivo glycocapture.

本文引用的文献

1
Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells.基于猪脑内皮细胞建立体外血脑屏障模型的改进方法
J Vis Exp. 2017 Sep 24(127):56277. doi: 10.3791/56277.
2
Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion.基底膜蛋白(CD147):一种参与生殖、神经功能、炎症和肿瘤侵袭的多功能跨膜蛋白。
Histol Histopathol. 2003 Jul;18(3):981-7. doi: 10.14670/HH-18.981.
3
The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily.
大鼠和小鼠血脑屏障的蛋白质组:通过体内糖捕获对脑微血管腔表面蛋白质进行高度特异性鉴定。
Fluids Barriers CNS. 2024 Mar 4;21(1):23. doi: 10.1186/s12987-024-00523-x.
4
Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.用于中枢神经系统药物递送的针对血脑屏障受体介导的转胞吞作用系统的抗体的鉴定、工程和验证策略。
Expert Opin Drug Deliv. 2023 Jul-Dec;20(12):1789-1800. doi: 10.1080/17425247.2023.2286371. Epub 2023 Dec 29.
5
Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier.不同受体类型在血脑屏障治疗性抗体递送上的亚细胞转运和转胞吞作用效率。
Fluids Barriers CNS. 2023 Nov 6;20(1):82. doi: 10.1186/s12987-023-00480-x.
6
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier.修饰抗体-FcRn 相互作用以增加抗体通过血脑屏障的转运。
MAbs. 2023 Jan-Dec;15(1):2229098. doi: 10.1080/19420862.2023.2229098.
7
Modelling a Human Blood-Brain Barrier Co-Culture Using an Ultrathin Silicon Nitride Membrane-Based Microfluidic Device.使用基于氮化硅薄膜的超薄微流控装置模拟人血脑屏障共培养物。
Int J Mol Sci. 2023 Mar 15;24(6):5624. doi: 10.3390/ijms24065624.
8
Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood-Brain Barrier.用于穿越血脑屏障的介孔二氧化硅纳米颗粒的尺寸与电荷效应桥接
Front Chem. 2022 Jun 27;10:931584. doi: 10.3389/fchem.2022.931584. eCollection 2022.
9
A Historical Review of Brain Drug Delivery.脑药物递送的历史回顾
Pharmaceutics. 2022 Jun 16;14(6):1283. doi: 10.3390/pharmaceutics14061283.
10
Transferrin-Enabled Blood-Brain Barrier Crossing Manganese-Based Nanozyme for Rebalancing the Reactive Oxygen Species Level in Ischemic Stroke.用于平衡缺血性中风中活性氧水平的转铁蛋白介导血脑屏障穿越的锰基纳米酶
Pharmaceutics. 2022 May 25;14(6):1122. doi: 10.3390/pharmaceutics14061122.
人肿瘤细胞衍生的胶原酶刺激因子(重新命名为EMMPRIN)是免疫球蛋白超家族的一员。
Cancer Res. 1995 Jan 15;55(2):434-9.